[Retracted] Clinical Observation of <i>Helicobacter pylori</i> Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease

<table class="table-group" id="tab12"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">Number of positive cases of cytotoxin-associated protein A</td><td class="align_center">Effective treatment</td><td class="align_center">Ineffective treatment</td><td class="align_center"><i>X </i><sup><i>2</i></sup> value</td><td class="align_center"><i>P</i> value</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td class="align_left">Gastric cancer group</td><td class="align_center">41</td><td class="align_center">28 (68.29)</td><td class="align_center">13 (31.71)</td><td class="align_center">4.512</td><td class="align_center">0.034</td></tr><tr><td class="align_left">Nontumor gastrointestinal diseases group</td><td class="align_center">63</td><td class="align_center">54(85.71)</td><td class="align_center">8(13.25)</td><td class="align_center"> </td><td class="align_center"> </td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of the effective rate of two groups according to <i>Helicobacter pylori</i> treatment <span class="nowrap"><svg height="11.5564pt" id="M51" style="vertical-align:-2.26807pt" version="1.1" viewbox="-0.0498162 -9.28833 36.7497 11.5564" width="36.7497pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z"></path></g><g transform="matrix(.013,0,0,-0.013,4.498,0)"><path d="M495 86L479 114C446 82 419 66 409 66C401 66 401 72 406 97C420 166 436 231 453 297C489 435 454 448 428 448C406 448 384 439 354 422C305 394 222 327 161 247H159L183 345C200 415 194 448 173 448C143 448 82 410 23 351L38 325C64 349 95 371 105 371C111 371 116 365 109 336L25 -4L31 -12C50 -4 77 3 107 9C119 69 132 122 145 168C197 254 321 381 370 381C387 381 393 374 378 305L329 95C309 17 320 -12 345 -12C372 -12 430 19 495 86Z"></path></g><g transform="matrix(.013,0,0,-0.013,13.2,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z"></path></g><g transform="matrix(.013,0,0,-0.013,17.698,0)"><path d="M594 629L561 652L159 -9L190 -32L594 629ZM194 635C92 635 49 534 49 453C49 374 92 272 193 272C295 272 338 374 338 454S295 635 194 635ZM193 605C257 605 265 504 265 453C265 405 257 302 194 302C133 302 122 403 122 454S133 605 193 605ZM567 351C465 351 421 250 421 169C421 90 465 -12 566 -12S710 90 710 170S667 351 567 351ZM566 322C628 322 637 221 637 169C637 121 628 18 567 18S494 119 494 170C494 223 506 322 566 322Z"></path></g><g transform="matrix(.013,0,0,-0.013,27.562,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z"></path></g><g transform="matrix(.013,0,0,-0.013,32.06,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z"></path></g></svg>.</span></div>

Contrast Media & Molecular Imaging

tab12

Table 12

Table 12: [Retracted] Clinical Observation of <i>Helicobacter pylori</i> Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease 

Table 12 | [Retracted] Clinical Observation of Helicobacter pylori Infection and Risk Factors and Cytotoxin-Associated Protein A in Patients with Coronary Heart Disease 